The Impact of Art Therapy on the Relationships Between Individuals Diagnosed With Alzheimer's Disease and Their Care Partners

NCT ID: NCT06725251

Last Updated: 2024-12-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

82 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-26

Study Completion Date

2022-08-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the impact of a 4-week art therapy intervention on the relationships between individuals diagnosed with Alzheimer's disease and their care partners, on the self-esteem of diagnosed individuals, and on care partner attitudes towards persons with Alzheimer's disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim is to develop and implement an art therapy intervention for dyads - each consisting of an individual diagnosed with mild Alzheimer's disease and his/her care partner - with the goals of improving patients' and care partners' sense of their relationship, increasing patients' self-esteem and improving care partner attitudes towards individuals with Alzheimer's disease. The specific intervention will be a portrait-making project utilizing a collage approach. Each participant (i.e. diagnosed individuals and care partners) will be instructed to create a portrait of him/herself. Participants will be provided with a sample portrait as well as bins of materials (e.g. words, images, markers). The intervention will be administered for 1 ½ hours weekly, at the same day/time, for 4 consecutive weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

self esteem caregiver art therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dementia Participants and Care Partners

Dyads including a participant diagnosed with dementia and the care partner

Group Type EXPERIMENTAL

Art Therapy

Intervention Type BEHAVIORAL

Dyads will take part in a portrait-making project utilizing a collage approach. Each participant (i.e. dementia diagnosed individuals and care partners) will be instructed to create a portrait of him/herself. Participants will be provided with a sample portrait as well as bins of materials. \]The intervention will be administered for 1 ½ hours weekly, at the same day/time, for 4 consecutive weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Art Therapy

Dyads will take part in a portrait-making project utilizing a collage approach. Each participant (i.e. dementia diagnosed individuals and care partners) will be instructed to create a portrait of him/herself. Participants will be provided with a sample portrait as well as bins of materials. \]The intervention will be administered for 1 ½ hours weekly, at the same day/time, for 4 consecutive weeks.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A diagnosis of Alzheimer's disease, based on the NIA/AA Diagnostic Guidelines for Alzheimer's Disease (McKhann et al., 2011)
* MMSE of 18-26, inclusive, administered within 6 month prior to screening or at screening
* Awareness of diagnosis and/or memory impairment, as determined by semi-structured interview with clinician (see Appendix B)
* Availability and willingness to participate in all 4 sessions of the intervention
* A care partner with whom the patient has regular weekly contact and who is available and willing to participate in all 4 sessions of the intervention
* Sufficient visual acuity to read 12-point font
* Sufficient manual dexterity to use scissors
* Ability to hear instructions in a classroom setting
* Ability to read English
* Age 18 years old or greater


* Adult 18 years of age or older
* Ability to consent
* Regular weekly contact with the subject diagnosed with Alzheimer's disease
* Availability and willingness to participate in all 4 sessions of the intervention
* Sufficient visual acuity to read 12-point font
* Sufficient manual dexterity to use scissors
* Ability to hear instructions in a classroom setting
* Ability to read English

Exclusion Criteria

* Any uncontrolled medical or neurological/neurodegenerative condition (other than AD) that, in the opinion of the Investigator, might be a contributing cause of the subject's cognitive impairment (e.g., substance abuse, vitamin B12 deficiency, abnormal thyroid function, stroke or other cerebrovascular condition, Lewy body dementia, fronto-temporal dementia, head trauma).
* Current active psychiatric illness (e.g., major depression, schizophrenia, etc.)
* Current active seizure disorder.
* Malignancy or carcinoma currently requiring active treatment or progressing off of treatment.
* Recent history (within 1 year) of alcohol abuse or drug abuse.
* Active tobacco use that interferes with visits (e.g., if the patient would need to smoke during the therapy session).
* Use of medications (e.g., narcotics, sedatives, etc.) that lead to drowsiness during the therapy sessions
* Inability to comply with the instructions of the art therapist.
* Other unspecified reasons that, in the opinion of the Investigator make the subject unsuitable for enrollment.
* Prisoners


* Any uncontrolled medical or neurological/neurodegenerative condition sufficient to cause cognitive impairment
* Current active psychiatric illness (e.g., major depression, schizophrenia, etc.)
* Current active seizure disorder.
* Malignancy or carcinoma currently requiring active treatment or progressing off of treatment.
* Recent history (within 1 year) of alcohol abuse or drug abuse.
* Active tobacco use that interferes with visits (e.g., if the care partner would need to smoke during the therapy session).

Use of medications (e.g., narcotics, sedatives, etc.) that lead to drowsiness during the therapy sessions

* Inability to comply with the instructions of the art therapist.
* Other unspecified reasons that, in the opinion of the Investigator make the care partner unsuitable for enrollment.
* Prisoners
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

James R. and Helen D. Russell Center for Research and Innovation

UNKNOWN

Sponsor Role collaborator

Wake Forest University Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Darren Gitelman, MD

Role: PRINCIPAL_INVESTIGATOR

Wake Forest University Health Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Advocate Memory Center

Park Ridge, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6409

Identifier Type: OTHER

Identifier Source: secondary_id

2016-102

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

IRB00106942

Identifier Type: -

Identifier Source: org_study_id